Intriguingly, RNA sequencing also revealed enhanced expression of Prdm1, a master regulator of plasma cell proliferation and differentiation, which was found to be essential for the survival of WM cells by regulating EZH2, a promising therapeutic target in B-cell lymphoma [49, 50]. The gene discussed is EZH2; the disease is B-cell non-Hodgkin lymphoma.